Ann: FOD Investor Presentation, page-26

well, ZNO's issued share capital is around 173 million shares and FOD's is around 724 million shares and there is a huge difference between their average annual turnover at this stage and that is priced into the prevailing stock price. Another notable difference between the two is that ZNO is a biotech company and FOD is not.

As much as I love FOD and am heavily invested into it, I wouldn't compare FOD with the likes of ZNO when it comes to stockprice movement. Any stock with high liquidity will struggle to jump like ZNO.

Let us hope FOD makes its mark during these tough times and gains MOMENTUM and stability.

GLTAH